Quantros Patient Safety Center Receives Certification as a Patient Safety Organiza... ( SAN FRANCISCO Dec. 8 /- Quantros a le...)

Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)

Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire/ -- Quantros, a leading provider of safety, quality, and compliance solutions for the healthcare industry, today announced that the Agency for Healthcare Research and Quality (AHRQ) has granted initial certification to Quantros Patient Safety Center as a Patient Safety Organization (PSO). The listing can be viewed at http://www.pso.ahrq.gov/listing/psolist.htm. The Quantros Patient Safety Center is a new division within Quantros that is specifically focused on review of safety processes, data analytics, and provision of associated knowledge content and complementary services to support healthcare providers using Quantros as a PSO to better address patient safety. Supporting healthcare providers in the improvement of safety and quality initiatives is in complete alignment with the mission and goals of the organization for more than nine years. Today more than 2,000 healthcare providers use one or more Quantros solutions for improving safety and quality within their care environment.

In addition to the Quantros Patient Safety Center, Quantros also supports other entities acting as a PSO with Quantros Patient Safety Organization (PSO) Manager, a streamlined, Web-based application that will enable PSOs to seamlessly aggregate required Common Format (CM) for event data as well as additional safety data for use as a confidential Patient Safety Work Product (PSWP). Just as with The Joint Commission ORYX Core Measures program, Quantros has chosen to act as both a technology provider and a PSO.

Dr. Sanjaya Kumar, Quantros President and CEO commented, "Quantros is in business to assist healthcare providers in advancing safety and quality improvement initiatives. The Quantros Patient Safety Center was created to further that cause for healthcare providers who want to leverage both Quantros and associated partner experti
'/>"/>

SOURCE Quantros
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
2. Quantros Expanding Support for Alternative Web Browsers
3. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
4. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
5. Electronic Prescribing Saves Patients Money
6. Confusing risk information may lead breast cancer patients to make poor treatment choices
7. Marital problems lead to poorer outcomes for breast cancer patients
8. Vitamin B1 could reverse early-stage kidney disease in diabetes patients
9. Lenalidomide safe as single therapy for elderly CLL patients
10. Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets.
11. CHOC Childrens Draws First Patient Dose With RIVA System

Post Your Comments:

(Date:4/17/2014)... chronic inflammation in benign prostate tissue was associated ... association was found even in those with low ... published in Cancer Epidemiology, Biomarkers & Prevention ... Cancer Research. , An analysis of prostate tissue ... arm of the Prostate Cancer Prevention Trial (PCPT) ...

(Date:4/17/2014)... popular vaccine brands for children may not be the ... cost factors when choosing vaccines, driving the market toward ... a new study by University of Illinois researchers. , ... by numerous factors," says Sheldon H. Jacobson, a co-author ... and of mathematics at the U. of I. "In ...

(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...

(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...

(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...

Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2 Health News:Chronic inflammation may be linked to aggressive prostate cancer 3 Health News:Study recalculates costs of combination vaccines 2 Health News:CU researchers discover target for treating dengue fever 2 Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2 Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2

[0] Chronic inflammation may be linked to aggressive prostate cancer [0] Study recalculates costs of combination vaccines [0] CU researchers discover target for treating dengue fever [0] Long-term effects of battle-related 'blast plus impact' concussive TBI in US military [0] New study says probiotic use for infant colic is not effective in reducing symptoms

... SXC Health Solutions, Inc.,("SXC" or the "Company") (NASDAQ: ... of,pharmacy benefits management services, announces that Mark Thierer,President ... Vice President,and Chief Financial Officer, will present at ... Grand Hyatt in New York City. SXC,s presentation,will ...

... Bermuda, Jan. 28 Warner Chilcott,Limited (Nasdaq: WCRX ) ... Total revenues for 2008 are expected to be in the ... driven by LOESTRIN 24 FE, DORYX,FEMCON FE, and TACLONEX. Gross ... be in the range of 80% to 81% in 2008., ...

... While many of today,s seniors are,retiring into what ... of life,they want to stay connected to the "real ... to trustworthy information and resources. In,addition, these adults are ... referrals for home repairs to coordinating personal,transportation and even ...

... NTY ), (http://www.NBTY.com ), a leading global manufacturer ... fiscal first quarter ended,December 31, 2007., For the ... were,$511 million compared to $506 million for the fiscal ... million or 1%., Net income for the fiscal ...

... Demo 08 -- Today, at DEMO 08,Acesis Inc. ... a,revolutionary on-demand electronic health record software solution. Acesis,Point-of-Care ... professionals by providing a secure, intuitive data capture,system ... "Acesis Point-of-Care is a striking example of ...

... 10 a.m. EST, January 28, 2008, WALTHAM, Mass., ... and Matria Healthcare, Inc. (Nasdaq: MATR ) today,announced ... to,which Inverness will acquire all outstanding shares of common ... cash plus $32.50 in,convertible preferred stock of Inverness (convertible ...

SXC Health Solutions to present at the 2008 UBS Global Healthcare Services Conference Warner Chilcott Announces 2008 Financial Guidance Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates NBTY Reports First Quarter Results Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.

(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...

(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014 Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity. These results ...

(Date:1/14/2014)... 2014 The Brandeis Medical Center, led by Dr. Emmanuel ... and affordable laser tattoo removal experience with the advanced Astanza Duality ... providing high quality cosmetic services with cutting edge medical technology and ... Southern California has seen a dramatic increase in the ...

[0] Insulin Pump Market & Forecast - Worldwide Analysis [0] Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome [0] Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special

... April 24 Novagali Pharma, an emerging,ophthalmic pharmaceutical ... first patient in a Phase I clinical trial ... technology platform,containing a corticosteroid prodrug for the treatment ... enrol a total of 15 patients, is,designed to ...

... CAMBRIDGE, Massachusetts, April 24, Shire plc (LSE: ... announces the acquisition of,arylsulfatase -A (ASA) an ... trials for Metachromatic Leukodystrophy (MLD) from the ... a serious, life-limiting disease in which patients ...

Cached Medicine Technology:Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema 2 Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy 2 Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy 3

Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

... higher magnification and increased stereopsis, the Central ... visualization to the equatorial regions. The Central ... and in membrane peeling in proliferative vitreoretinopathy ... Lenses The ACS Vitrectomy Lenses from Volk ...

... the high resolution, high magnification and field ... simple two part design separates for easy ... Simply autoclave, add saline or water to ... use. (ACS) AutoClave Sterilizable Lenses The ACS ...

... These patented ACS lenses offer the ... view as the original clariVits. The simple ... while maintaining its integrity during surgery. Simply ... contact element, then lock together for use. ...

... over a wide field ... entire retina, detailed retinal ... tears, diagnosis and treatment ... the vitreous cavity is ...

Medicine Products:

Central Retinal (ACS)clariVit Central Mag. (ACS)clariVit Wide Angle (ACS)clariVit Wide Angle